Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases

Scandinavian Journal of Immunology

Volumn 69, Issue 3, 2009, Pages 268-274

  Vasakova, M ^a   Sterclova, M ^a   Kolesar, L ^b   Slavcev, A ^b   Pohunek, P ^c   Sulc, J ^c   Skibova, J ^b   Striz, I ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; CHEMOKINE; CYTOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN 10BETA; INTERLEUKIN 17BETA; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2BETA; INTERLEUKIN 4BETA; INTERLEUKIN 5BETA; INTERLEUKIN 6BETA; INTERLEUKIN 8; INTERLEUKIN 8BETA; INTERLEUKIN DERIVATIVE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; THROMBOPOIETIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; ALLERGIC PNEUMONITIS; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOCHEMISTRY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE MARKER; FEMALE; FIBROSING ALVEOLITIS; HUMAN; INTERSTITIAL LUNG DISEASE; LEUKOCYTE DIFFERENTIAL COUNT; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG SARCOIDOSIS; MALE; PRIORITY JOURNAL; PROGNOSIS;

BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CYTOKINES; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS;

EID: 60449091290     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02222.x     Document Type: Article

References (28)

1. Scotton CJ, Chambers RC. Molecular targets in pulmonary fibrosis. The myofibroblasts in focus. Chest 2007 132 (Suppl. 4 1311 21.
2. Pignatti P, Brunetti G, Moretto D et al. Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis. Am J Respir Crit Care Med 2006 173 : 310 7.
3. Petrek M, Kolek V, Szotkowska M, du Bois RM. CC and C chemokine expression in pulmonary sarcoidosis. Eur Respir J 2002 20 : 1206 12.
4. Nishioka Y, Manabe K, Kishi J et al. CXCL9 and 11 in patients with pulmonary sarcoidosis a role of alveolar macrophages. Clin Exp Immunol 2007 149 (Suppl. 2 317 26.
5. Fujishima S, Nakamura M, Nakamura H et al. Flow cytometric detection of cell-associated interleukin-8 in alveolar macrophages in vivo from patients with hypersensitivity pneumonitis and sarcoidosis. Scand J Clin Lab Invest 2004 64 (Suppl. 3 237 43.
6. Schuyler M, Gott K, Cherne A. Mediators of hypersensitivity pneumonitis. J Lab Clin Med 2000 136 (Suppl. 1 29 38.
7. Schuyler M, Gott K, Cherne A. Experimental hypersensitivity pneumonitis: role of MCP-1. J Lab Clin Med 2003 142 (Suppl. 3 187 95.
8. Schuyler M, Gott K, French V. The role of MIP-1alpha in experimental hypersensitivity pneumonitis. Lung 2004 182 (Suppl. 3 135 49.
9. Antoniou KM, Tzouvelekis A, Alexandrakis G et al. Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest 2006 130 : 982 8.
10. Prasse A, Pechkovsky DV, Toews GB et al. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. Arthritis Rheum 2007 56 (Suppl. 5 1685 93.
11. Prasse A, Pechkovsky DV, Toews GB et al. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am J Respir Crit Care Med 2006 173 : 781 92.
12. Capelli A, Di Stefano I, Gnemmi I, Donner CF. CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis. Eur Respir J 2005 25 : 701 7.
13. Capelli A, Di Stefano A, Lusuardi M, Gnemmi I, Donner CF. Increased macrophage inflammatory protein-1alpha and macrophage inflammatory protein-1beta levels in bronchoalveolar lavage fluid of patients affected by different stages of pulmonary sarcoidosis. Am J Respir Crit Care Med, 2002 165 : 236 41.
14. Zhu Z, Ma B, Zheng T et al. IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13 induced inflammation and remodeling. J Immunol 2002 168 : 2953 62.
15. Antoniou KM, Tzanakis N, Tzortzaki EG et al. Different angiogenic CXC chemokine levels in bronchoalveolar lavage fluid after interferon gamma-1b therapy in idiopathic pulmonary fibrosis patients. Pulm Pharmacol Ther 2008 21 : 840 4.
16. Keane MP, Arenberg DA, Lynch JP III. et al. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 1997 159 (Suppl. 3 1437 43.
17. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000 161 : 646 64.
18. Working party: standardized lung function testing, ECSC. Eur Respir J 1993 6 (Suppl.) 16 : 5 40.
19. Meyer KC, Cardoni A, Xiang ZZ. Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease. J Clin Lab Med 2000 4 : 332 8.
20. Koyama S, Sato E, Haniuda M, Numanami H, Nagai S, Izumi T. Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. Am J Respir Crit Care Med 2002 166 (Suppl. 3 382 5.
21. Navarro C, Ruiz V, Gaxiola M, Carrillo G, Selman M. Angiogenesis in hypersensitivity pneumonitis. Arch Physiol Biochem 2003 111 (Suppl. 4 365 8.
22. Ebina M, Shimizukawa M, Shibata N et al. Heterogenous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2004 169 : 1203 8.
23. Cosgrove GP, Brown KK, Schiemann WP et al. Pigment epithelium-derived factor in idiopathic pulmonary fibrosis. A role in aberrant angiogenesis. Am J Respir Crit Care Med 2004 170 : 242 51.
24. Keane MP, Belperio JA, Burdick MD, Lynch JP, Fishbein MC, Strieter RM. ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001 164 (Suppl. 12 2239 42.
25. Pantelidis P, Southcott AM, Black CM, Du Bois RM. Up-regulation of IL-8 secretion by alveolar macrophages from patients with fibrosing alveolitis: a subpopulation analysis. Clin Exp Immunol 1997 108 (Suppl. 1 95 104.
26. Mikuniya T, Nagai S, Takeuchi M et al. Significance of the interleukin-1 receptor antagonist/interleukin-1 beta ratio as a prognostic factor in patients with pulmonary sarcoidosis. Respiration 2000 67 (Suppl. 4 389 96.
27. Mikuniya T, Nagai S, Shimoji T et al. Quantitative evaluation of the IL-1 beta and IL-1 receptor antagonist obtained from BALF macrophages in patients with interstitial lung diseases. Sarcoidosis Vasc Diffuse Lung Dis 2007 14 (Suppl. 1 39 45.
28. Roberts JR, Perkins GD, Fujisawa T et al. Vascular endothelial growth factor promotes physical wound repair and is anti-apoptotic in primary distal lung epithelial and A549 cells. Crit Care Med 2007 35 (Suppl. 9 2164 70.